What is Andromeda?
Andromeda is an Australian robotics company focused on the development of Abi, a personalized robotic companion designed to foster meaningful connections and enhance the capacity of care teams. The company operates within the burgeoning field of assistive robotics and AI-driven companionship, aiming to bring joy and improved care through technological innovation. Its core mission revolves around creating empathetic robotic solutions that bridge gaps in personal care and social connection.
How much funding has Andromeda raised?
Andromeda has raised a total of $28.9M across 2 funding rounds:
Series A
$14.8M
Private Equity
$14.1M
Series A (2025): $14.8M with participation from Main Sequence Ventures, Forerunner Ventures, Rethink Impact, and Artesian
Private Equity (2025): $14.1M, investors not publicly disclosed
Key Investors in Andromeda
Main Sequence Ventures
Main Sequence is a venture capital firm focused on deeptech, collaborating with inventors who leverage their scientific expertise to create transformative industries. The firm aims to accelerate the growth of companies addressing significant global challenges, such as space exploration, decarbonization, and healthcare. Main Sequence invests in founders with an 'unreasonable belief' in their ability to achieve the impossible.
Forerunner Ventures
Forerunner Ventures partners with founders to build category-defining companies at the intersection of technology and human behavior. They focus on identifying emerging technology trends and consumer demands to invest in innovative startups. Their portfolio includes companies like Chime, Hims & Hers, and Oura, which are transforming various industries such as finance, wellness, and health tracking.
Rethink Impact
Rethink Impact is a venture capital firm that invests in entrepreneurs, technology platforms, and networks focused on creating ecosystems of change. The firm targets leaders who utilize technology to address significant global challenges across various sectors, including healthcare, economic opportunity, environmental sustainability, and education.
What's next for Andromeda?
With this substantial enterprise-level backing, Andromeda is poised for accelerated growth and market expansion. The strategic investment signals confidence from investors in the company's vision and its potential to disrupt the healthcare and personal assistance sectors. Future developments are likely to focus on scaling production of Abi, enhancing its AI capabilities for deeper user engagement, and expanding its reach to new markets. The company's trajectory suggests a strong emphasis on integrating advanced robotics with empathetic design to address evolving societal needs in care and companionship.
See full Andromeda company page
